2026-526090-42-00招募中1 期
A study to test how well different and multiple doses of BI 3034701 are tolerated in people living with overweight or obesity
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 35
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
CT Disclosure & Data Transparency
Scientific
Boehringer Ingelheim International GmbH
研究点 (3)
Loading locations...
相似试验
招募中
1 期
A study to investigate the effects of multiple doses of obefazimod on a combined oral contraceptive (ethinyl estradiol/drospirenone) in healthy female participants of childbearing potential.2023-505297-15-00Abivax, Abivax36
招募中
1 期
A study to evaluate how well single and multiple doses of S072 are tolerated in healthy adult participantsPain2025-525039-15-01Sea4us Biotecnologia E Recursos Marinhos S.A.64
招募中
1 期
A study to test whether different combinations of BI 765063, ezabenlimab, chemotherapy, cetuximab, and BI 836880 help people with head and neck cancer or liver cancerhepatocellular carcinoma2024-512799-36-00Boehringer Ingelheim International GmbH18
已完成
1 期
A research study comparing the effect of different dosing conditions on blood levels of semaglutide in a new tablet composition in healthy participantsType 2 Diabetes2023-503949-65-00Novo Nordisk A/S120
招募中
1 期
An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation2023-507630-25-00Ferring Pharmaceuticals A/S600